USEOFFLOWCYTOMETRYTOSTUDY DRUG TARGET INHIBITION IN LABORATORY ANIMALS AND IN EARLY-PHASE CLINICAL TRIALS - Flow Cytometry in Drug Discovery and Development - page 164

42. Donnenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited: the cancer
stem cell hypothesis. J. Clin. Pharmacol. 2005;45(8):872-877.
43. Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, et al. Regulation of
breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res.
2010;70(2):709-718.
44. Ischenko I, Seeliger H, Schaffer M, Jauch KW, Bruns CJ. Cancer stem cells: how can we
target them? Curr. Med. Chem. 2008;15(30):3171-3184.